The concept of essential medicines: lessons for rich countriesBMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7475.1169 (Published 11 November 2004) Cite this as: BMJ 2004;329:1169
w1 Doctors without borders. Translating the essential drugs concept into the context of the year 2000. Unpublished background paper for a workshop held on 19 September 2000, Geneva.
w2 United National Conference on Trade and Development. Technology policies in the pharmaceutical sector in Cuba. New York: United Nations; 1980. (Document UNCTAD/TT/33.)
w3 Van Amelsvoort V. Standard notes for Tanzanian dispensaries. Dar es Salaam: Dar es Salaam University, Department of Preventive and Social Medicines, 1970. (Experimental edition.)
w4 Ministerio de Salud. Vademecum official de medicamentos basicos del sector salud. Lima, Peru: Ministerio de Salud; 1972.
w5 Therapeutic Guidelines. Therapeutic guidelines: antibiotic. Version 12. North Melbourne, Australia: Therapeutic Guidelines, 2003.
w6 Papua New Guinea. Standard treatments for common illnesses of children in Papua New Guinea. Port Moresby: Department of Health, 1974.
w7 Ministério da Saude. Guia terapéutico. Maputo, Mozambique: Ministério da Saude, 1981.
w8 World Health Organization. Background document for the 31st World Health Assembly. w9 Geneva: WHO; 1978; A/31 Technical discussions/1.
Department of Health. Philippine national drug policy. Manila: Department of Health; 1988.
w10 National drug policy of South Africa. Pretoria: Ministry of Health, 1996.
- This Week In The BMJ Published: 11 November 2004; BMJ 329 doi:10.1136/bmj.329.7475.0-c
- Education And Debate Published: 11 November 2004; BMJ 329 doi:10.1136/bmj.329.7475.1172
- Letter Published: 24 February 2005; BMJ 330 doi:10.1136/bmj.330.7489.479
- Distilling ethics, compassion, science and the art of medicineBMJ December 05, 2016, 355 i6510; DOI: https://doi.org/10.1136/bmj.i6510
- Manufacturers tell FDA why they should be able to promote drugs and devices off labelBMJ November 14, 2016, 355 i6098; DOI: https://doi.org/10.1136/bmj.i6098
- How medicine has exploited rationality at the expense of humanity: an essay by Iona HeathBMJ November 01, 2016, 355 i5705; DOI: https://doi.org/10.1136/bmj.i5705
- CCG is criticised for paying private firm to screen referralsBMJ October 26, 2016, 355 i5765; DOI: https://doi.org/10.1136/bmj.i5765
- Low intensity pulsed ultrasound for fractures of the tibial shaft.BMJ October 25, 2016, 355 i5652; DOI: https://doi.org/10.1136/bmj.i5652
- Relation between opioid consumption and inclusion of opioids in 137 national essential medicines lists
- Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada
- WHO and national lists of essential medicines in Mexico, Central and South America, and the Caribbean: are they adequate to promote paediatric endocrinology and diabetes care?
- Learning from low income countries: Poor patients deserve more science and less advocacy
- The pros and cons of essential medicines for rich countries